Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

USA CPI (YoY) for Oct 6.200% vs 5.300% Est; Prior 5.400%

USA CPI (YoY) for Oct 6.200% vs 5.300% consensus estimate. The prior reading was 5.400%.
byBenzinga Newsdesk
November 10, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

USA CPI (YoY) for Oct 6.200% vs 5.300% consensus estimate. The prior reading was 5.400%.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AbbVie Earlier Announced European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Moderate to Severe Active Crohn’s Disease

By Charles Gross
Today, 2:06 AM
AbbVie (NYSE: ABBV) announced the European Commission (EC) approved SKYRIZI® (risankizumab, 600 mg intravenous [IV] induction and 360 mg subcutaneous [SC] maintenance therapy) as the first specific interleukin-23 (IL-23) inhibitor for the treatment of adults with moderately to severely active Crohn's disease who have had in

ABBV